Citigroup »

Eiger Biopharmaceuticals shares owned by Citigroup

Quarter-by-quarter ownership of Eiger Biopharmaceuticals shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Eiger Biopharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eiger Biopharmaceuticals held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eiger Biopharmaceuticals by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $535 2.9k 0.18
2023-09-30 $1.1k 3.7k 0.30
2023-03-31 $3.1k 3.4k 0.90
2022-12-31 $14k 12k 1.18
2022-09-30 $32k 4.2k 7.63
2021-12-31 $72k 15k 5.00
2021-03-31 $72k 8.2k 8.82
2020-12-31 $791k 64k 12.29
2020-09-30 $489k 60k 8.15
2020-06-30 $581k 61k 9.60
2020-03-31 $432k 64k 6.80
2019-12-31 $100k 6.7k 14.85
2019-09-30 $19k 1.9k 9.86
2019-06-30 $77k 7.3k 10.55
2019-03-31 $394k 28k 13.99
2018-12-31 $1.0k 133 7.52
2018-09-30 $2.0k 133 15.04
2018-06-30 $2.0k 133 15.04
2018-03-31 $1.0k 133 7.52
2017-12-31 $2.0k 133 15.04
2017-09-30 $1.0k 133 7.52
2017-06-30 $1.0k 133 7.52
2017-03-31 $3.5k 312 11.17
2016-12-31 $0 136 0.00
2016-09-30 $2.0k 133 15.04
2016-06-30 $11k 526 20.11